receptorbind
domain
rbd
locat
toxin
toxin
b
clostridium
difficil
known
nontox
immunogen
need
develop
new
type
vaccin
base
rbd
studi
express
purifi
recombin
protein
name
rbdtcda
rbdtcdb
vaccin
candid
contain
rbd
toxin
toxin
b
respect
c
difficil
refer
strain
immunogen
protect
vaccin
candid
rbdtcda
rbdtcdb
rbdtcdab
evalu
elisa
surviv
assay
data
indic
mice
immun
vaccin
candid
display
potent
level
rbdspecif
serum
igg
follow
intramuscular
immun
mice
rbdtcda
andor
rbdtcdb
vaccin
candid
trigger
immun
respons
protect
mice
compar
mice
immun
aluminum
hydroxid
alon
taken
togeth
result
studi
reveal
recombin
protein
contain
rbd
c
difficil
toxin
use
vaccin
develop
addit
found
rbdtcdab
vaccin
elicit
stronger
humor
immun
respons
provid
better
immunoprotect
unival
vaccin
rbd
vaccin
candid
confer
signific
protect
diseas
symptom
death
caus
toxin
wildtyp
c
difficil
strain
clostridium
difficil
clostridiod
difficil
gramposit
sporeform
anaerob
rod
bacterium
bare
receiv
attent
discov
associ
pseudomembran
coliti
caus
case
antibioticassoci
diarrhea
current
prognosi
c
difficil
infect
cdi
alarm
mortal
rate
recurr
rate
rang
unit
state
cdi
respons
infect
approxim
death
healthcar
cost
exceed
billion
per
year
cdi
caus
new
strain
belong
ribotyp
spread
worldwid
result
larg
number
death
legal
surveil
list
mani
countri
includ
china
pathogen
caus
infecti
diseas
besid
use
effect
antibiot
fecal
microbiota
transplant
fmt
immunoprophylaxi
gener
consid
effect
prefer
control
strategi
toxin
toxin
b
major
virul
determin
bacterium
immun
two
toxin
provid
protect
inhibit
action
toxin
effect
prevent
seriou
ill
caus
cdi
toxin
enterotoxin
cytotoxin
high
toxic
toxin
b
potent
cytotoxin
toxic
time
high
toxin
vaccin
develop
search
vaccin
candid
high
immunogen
low
toxic
need
make
chang
toxin
develop
new
vaccin
type
toxin
toxin
b
singlechain
polypeptid
consist
highli
conserv
ntermin
catalyt
domain
modifi
gtpase
transloc
domain
autoproteolyt
domain
receptorbind
domain
rbd
threedimension
structur
glucosyltransferas
domain
portion
rbd
well
defin
known
nativ
receptor
toxin
sequenc
found
human
intestin
epitheli
cell
human
receptor
toxin
b
identifi
crystal
structur
toxin
fragment
indic
toxin
rbd
possess
seven
carbohydr
bind
site
toxin
b
predict
four
site
bind
receptor
rbd
essenti
toxic
c
difficil
toxin
b
inhibit
bind
protect
host
ill
caus
toxin
usual
rbd
known
nontox
immunogen
rbd
use
vaccin
candid
among
other
sar
coronaviru
c
botulinum
studi
construct
recombin
protein
contain
fulllength
rbd
toxin
toxin
b
name
rbdtcda
rbdtcdb
respect
refer
strain
ribotyp
immun
mice
recombin
rbdtcda
andor
rbdtcdb
test
immunogen
protect
effect
toxin
extract
wildtyp
strain
american
type
cultur
collect
atcc
belong
ribotyp
anim
studi
conduct
accord
beij
institut
microbiolog
epidemiolog
anim
care
use
committe
guidelin
wildtyp
mice
week
old
weigh
g
obtain
institut
laboratori
anim
center
beij
china
experiment
mice
bred
specif
pathogenfre
facil
institut
refer
strain
wildtyp
strain
atcc
c
difficil
purchas
american
type
cultur
collect
atcc
center
sequenc
gene
encod
toxin
toxin
b
wildtyp
strain
vero
cell
line
kept
lab
amino
acid
sequenc
correspond
rbd
c
difficil
rbdtcda
strain
residu
posit
rbdtcdb
strain
residu
posit
amplifi
pcr
genom
c
difficil
two
gene
fragment
insert
vector
novagen
darmstadt
germani
contain
polyhistidin
tag
ndei
xhoi
restrict
site
result
rbd
construct
transform
e
coli
transgen
beje
china
subsequ
protein
express
purif
recombin
protein
express
success
transform
bacteria
induct
iptg
luriabertani
medium
purifi
ni
hitrap
chelat
ml
prepack
column
ge
healthcar
bioscienc
corp
piscataway
nj
usa
use
imidazol
elut
reagent
lysat
transform
cell
purifi
protein
identifi
sodium
dodecylsulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
purif
step
analyz
sdspage
rbdtcda
rbdtcdb
separ
sampl
separ
gel
electrotransf
pvdf
membran
ge
step
follow
antigenantibodi
reaction
rabbit
antic
difficil
hyperimmun
sera
use
detect
antibodi
horseradish
peroxidaseconjug
goat
antirabbit
immunoglobulin
g
igg
serv
secondari
antibodi
follow
addit
substrat
diaminobenzidin
specif
protein
band
reveal
two
c
difficil
strain
grown
brain
heart
infus
bhi
becton
dickinson
compani
c
h
cell
remov
centrifug
cultur
supernat
precipit
satur
nh
overnight
c
centrifug
rpm
min
precipit
dissolv
mm
trishcl
ph
dialyz
mm
pb
ph
c
h
toxin
filtrationsteril
pore
size
membran
store
c
sampl
analyz
sdspage
western
blot
toxin
toxin
b
purifi
use
deae
sepharoseff
molecular
weight
measur
use
nativepag
method
toxic
determin
use
vero
cell
mice
brief
vero
cell
seed
plate
densiti
cell
per
well
incub
vero
cell
crude
toxin
result
loss
cell
adher
chang
cell
morpholog
observ
microscop
calcul
dose
caus
vero
cell
round
ed
vivo
experi
treat
mice
micegroup
group
serial
tenfold
diluent
crude
toxin
monitor
surviv
rate
minim
dose
caus
complet
lethal
mld
mice
calcul
reedmuench
method
mice
immun
intramuscularli
differ
dose
rbdtcda
rbdtcdb
rbdtcatcdb
day
day
aluminum
hydroxid
adjuv
mice
harvest
experi
mice
challeng
assay
control
vaccin
aluminum
hydroxid
pb
serum
sampl
serolog
analysi
collect
day
mice
challeng
crude
toxin
atcc
day
intraperiton
inject
crude
toxin
dose
rang
mld
mld
mice
monitor
daili
unrespons
recumb
anim
consid
moribund
euthan
moribund
mice
dissect
patholog
analysi
small
intestin
presenc
serum
igg
subtyp
specif
vaccin
candid
determin
indirect
elisa
briefli
crude
toxin
c
difficil
strain
dilut
carbon
buffer
ph
use
coat
well
overnight
incub
c
plate
wash
block
incub
serial
dilut
sera
h
room
temperatur
follow
anoth
wash
igg
isotypespecif
rabbit
antimous
horseradish
peroxidas
conjug
ad
appropri
dilut
min
incub
room
temperatur
plate
wash
substrat
solut
ad
well
reaction
stop
addit
sulfur
acid
well
absorb
develop
color
measur
nm
cutoff
valu
assay
calcul
mean
specif
od
plu
standard
deviat
sd
serum
sampl
assay
dilut
nonimmun
mice
titer
serum
calcul
reciproc
highest
serum
dilut
yield
specif
od
higher
cutoff
valu
assay
perform
triplic
repeat
three
time
neutral
antibodi
detect
perform
mtt
assay
briefli
heatinactiv
serum
immun
mice
serial
dilut
dmem
contain
fetal
calf
serum
mix
equal
volum
crude
toxin
ie
ng
toxin
ng
toxin
b
incub
c
h
mixtur
ad
plate
contain
vero
cell
incub
co
c
h
result
detect
mtt
stain
toxintr
vero
cell
discard
nonadher
cell
plate
read
microtit
plate
reader
wavelength
nm
intestin
tissu
fix
neutral
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
patholog
foci
ie
area
larg
number
inflammatori
cell
infiltr
accompani
evid
edema
submucosa
section
evalu
repres
photomicrograph
taken
magnif
statist
analys
perform
use
program
graphpad
softwar
inc
lajolla
ca
usa
valu
express
mean
sd
data
analyz
unpair
student
ttest
normal
distribut
oneway
anova
follow
dunnett
multipl
comparison
test
surviv
data
analyz
logrank
test
valu
p
consid
statist
signific
evalu
rel
role
two
rbd
vaccin
induc
immun
respons
protect
immun
toxin
express
purifi
two
protein
rbdtcda
rbdtcdb
fragment
encod
ctermin
rbd
toxin
toxin
b
gener
produc
recombin
protein
respect
insert
vector
contain
success
insert
gene
fragment
plasmid
verifi
restrict
digest
pcr
figur
c
recombin
protein
rbdtcda
rbdtcdb
purifi
niaffin
chromatographi
purif
process
yield
product
puriti
purifi
protein
visual
western
blot
protein
protein
appear
shown
figur
molecular
mass
correspond
rbdtcda
rbdtcdb
respect
intestin
tissu
fix
neutral
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
patholog
foci
ie
area
larg
number
inflammatori
cell
infiltr
accompani
evid
edema
submucosa
section
evalu
repres
photomicrograph
taken
magnif
statist
analys
perform
use
program
graphpad
softwar
inc
lajolla
ca
usa
valu
express
mean
sd
data
analyz
unpair
student
ttest
normal
distribut
oneway
anova
follow
dunnett
multipl
comparison
test
surviv
data
analyz
logrank
test
valu
p
consid
statist
signific
evalu
rel
role
two
rbd
vaccin
induc
immun
respons
protect
immun
toxin
express
purifi
two
protein
rbdtcda
rbdtcdb
fragment
encod
ctermin
rbd
toxin
toxin
b
gener
produc
recombin
protein
respect
insert
vector
contain
success
insert
gene
fragment
plasmid
verifi
restrict
digest
pcr
figur
c
recombin
protein
rbdtcda
rbdtcdb
purifi
niaffin
chromatographi
purif
process
yield
product
puriti
purifi
protein
visual
western
blot
protein
protein
appear
shown
figur
molecular
mass
correspond
rbdtcda
rbdtcdb
respect
chose
challeng
immun
mice
studi
crude
toxin
extract
bacteria
mice
sensit
cdi
obtain
crude
toxin
toxin
b
atcc
first
precipit
cultur
supernat
nh
obtain
crude
toxin
toxin
toxin
b
purifi
use
deae
sepharos
ff
figur
molecular
mass
measur
use
nativepag
purifi
protein
store
c
c
mention
method
section
use
elisa
experi
shown
figur
toxin
show
correct
molecular
mass
ident
confirm
elisa
toxin
toxin
b
mean
challeng
mice
cell
use
crude
toxin
test
toxic
mld
mice
ng
atcc
ed
vero
cell
pg
figur
vaccin
x
chose
challeng
immun
mice
studi
crude
toxin
extract
bacteria
mice
sensit
cdi
obtain
crude
toxin
toxin
b
atcc
first
precipit
cultur
supernat
obtain
crude
toxin
toxin
toxin
b
purifi
use
deae
sepharos
ff
figur
molecular
mass
measur
use
nativepag
purifi
protein
store
mention
method
section
use
elisa
experi
shown
figur
toxin
show
correct
molecular
mass
ident
confirm
elisa
toxin
toxin
b
mean
challeng
mice
cell
use
crude
toxin
test
toxic
mld
mice
ng
atcc
vero
cell
pg
figur
human
strong
humor
toxinspecif
immun
respons
elicit
cdi
associ
recoveri
lack
diseas
recurr
wherea
insuffici
humor
respons
associ
recurr
cdi
therefor
studi
test
humor
immun
respons
evalu
toxinspecif
antibodi
titer
evalu
humor
toxinspecif
immun
respons
elicit
rbdtcda
rbdtcdb
mice
vaccin
twice
intramuscularli
rbdtcda
rbdtcdb
rbdtcdab
indic
day
serum
sampl
collect
evalu
elisa
data
indic
immun
mice
display
potent
level
rbdspecif
serum
igg
figur
b
expect
anim
immun
pb
display
antigenspecif
respons
data
shown
antirbdtcda
antirbdtcdb
antibodi
titer
detect
day
increas
quickli
maintain
highlevel
titer
day
figur
b
increas
human
strong
humor
toxinspecif
immun
respons
elicit
cdi
associ
recoveri
lack
diseas
recurr
wherea
insuffici
humor
respons
associ
recurr
cdi
therefor
studi
test
humor
immun
respons
evalu
toxinspecif
antibodi
titer
evalu
humor
toxinspecif
immun
respons
elicit
rbdtcda
rbdtcdb
mice
vaccin
twice
intramuscularli
rbdtcda
rbdtcdb
rbdtcdab
indic
day
serum
sampl
collect
evalu
elisa
data
indic
immun
mice
display
potent
level
rbdspecif
serum
igg
figur
b
expect
anim
immun
pb
display
antigenspecif
respons
data
shown
antirbdtcda
antirbdtcdb
antibodi
titer
detect
day
increas
quickli
maintain
highlevel
titer
day
figur
b
increas
immun
dose
rbdtcda
rbdtcdb
rbdtcdab
measur
higher
titer
igg
comparison
group
immun
lower
dose
figur
presenc
antibodi
subtyp
specif
vaccin
candid
determin
indirect
elisa
found
signific
increas
absorb
antigenspecif
figur
f
sera
immun
mice
comparison
control
next
evalu
neutral
antibodi
level
sera
immun
mice
neutral
certain
dose
crude
toxin
vitro
neutral
assay
titer
neutral
antibodi
induc
rbdtcdab
vaccin
much
higher
two
unival
vaccin
tabl
immun
dose
rbdtcda
rbdtcdb
rbdtcdab
measur
higher
titer
igg
comparison
group
immun
lower
dose
figur
presenc
antibodi
subtyp
specif
vaccin
candid
determin
indirect
elisa
found
signific
increas
absorb
antigenspecif
figur
f
sera
immun
mice
comparison
control
next
evalu
neutral
antibodi
level
sera
immun
mice
neutral
certain
dose
crude
toxin
vitro
neutral
assay
titer
neutral
antibodi
induc
rbdtcdab
vaccin
much
higher
two
unival
vaccin
tabl
vaccin
candid
induc
high
titer
neutral
antibodi
neutral
antibodi
titer
avg
although
vaccin
approach
hold
great
potenti
cdi
prevent
immunoprotect
cdi
yet
achiev
sinc
use
toxin
wildtyp
atcc
strain
c
difficil
challeng
mice
studi
need
verifi
similar
toxin
atcc
hypervirul
strain
toxin
gene
id
toxin
b
gene
id
toxin
gene
id
toxin
b
gene
id
result
show
gene
toxin
atcc
strain
ident
two
rt
strain
publish
genbank
howev
rbd
amino
acid
sequenc
toxin
b
atcc
strain
show
similar
refer
strain
respect
figur
studi
protect
effect
recombin
protein
mice
immun
rbdtcda
rbdtcdb
rbdtcdab
two
immun
inocul
crude
toxin
atcc
result
show
rbdtcda
rbdtcdb
rbdtcdab
protect
mice
mld
toxin
prolong
life
figur
increas
immun
dose
three
vaccin
still
protect
mice
mld
crude
toxin
prolong
life
figur
big
differ
effect
two
immun
dose
mice
challeng
mld
mice
challeng
dose
mld
crude
toxin
mice
immun
rbdtcdab
surviv
mice
immun
rbdtcda
surviv
rbdtcdbvaccin
group
control
group
survivor
mice
challeng
dose
mld
crude
toxin
mice
immun
rbdtcdab
surviv
group
receiv
rbdtcdab
survivor
tabl
vaccin
x
similar
result
observ
two
independ
experi
surviv
data
analyz
logrank
test
histolog
evalu
reveal
intestin
patholog
typic
toxin
mice
receiv
high
dose
toxin
show
mani
inflammatori
foci
variou
degre
cellular
damag
evid
edema
submucosa
figur
main
differ
experiment
group
follow
nonimmun
mice
cellular
infiltr
tend
comparison
mice
immun
aluminum
hydroxid
vaccin
candid
increas
surviv
rate
p
n
micegroup
b
surviv
rate
wildtyp
mice
immun
recombin
vaccin
challeng
mld
crude
toxin
comparison
mice
immun
aluminum
hydroxid
vaccin
candid
increas
surviv
rate
p
n
micegroup
similar
result
observ
two
independ
experi
surviv
data
analyz
logrank
test
rbdtcda
rbdtcdb
rbdtcdab
rbdtcda
rbdtcdb
rbdtcdab
histolog
evalu
reveal
intestin
patholog
typic
toxin
mice
receiv
high
dose
toxin
show
mani
inflammatori
foci
variou
degre
cellular
damag
evid
edema
submucosa
figur
main
differ
experiment
group
follow
nonimmun
mice
cellular
infiltr
tend
medium
larg
size
frequent
associ
larg
area
necrosi
edema
submucosa
figur
mice
immun
rbdtcdab
figur
rbdtcdab
figur
challeng
mld
crude
toxin
display
sporad
small
site
inflamm
mice
immun
rbdtcdab
figur
rbdtcdab
figur
challeng
mld
crude
toxin
display
sporad
site
inflamm
littl
bigger
mice
challeng
mld
crude
toxin
quantit
score
expert
reveal
significantli
greater
percentag
lesion
unimmun
mice
show
evid
necrosi
edema
submucosa
p
recent
year
increas
occurr
cdi
relat
certain
risk
factor
especi
use
antibiot
usual
treatment
cdi
costli
recurr
rate
high
recent
year
fmt
promis
method
cdi
recent
year
increas
occurr
cdi
relat
certain
risk
factor
especi
use
antibiot
usual
treatment
cdi
costli
recurr
rate
high
recent
year
fmt
promis
method
cdi
treatment
limit
data
fmt
treatment
primari
cdi
fmt
appear
safe
effect
recurr
cdi
diseas
prevent
still
import
approach
deserv
explor
mention
toxin
toxin
b
major
virul
determin
c
difficil
bind
receptor
rbd
essenti
toxic
block
bind
site
protect
host
ill
caus
toxin
immun
recombin
rbd
repres
promis
method
vaccin
develop
number
studi
demonstr
antibodi
induc
rbdbase
vaccin
effici
block
toxic
bacteri
viral
replic
tissu
sever
c
difficil
vaccin
candid
exist
worldwid
one
vaccin
c
difficil
develop
sanofi
pasteur
develop
bival
candid
vaccin
formalininactiv
highli
purifi
prepar
toxin
although
signific
immun
respons
evok
remain
quit
difficult
develop
kind
vaccin
especi
difficult
obtain
highli
pure
natur
toxin
novavax
develop
chimer
toxin
receptorbind
domain
vaccin
induc
protect
cdi
linker
chimer
vaccin
may
alter
structur
protein
sometim
simpl
design
use
vaccin
develop
optim
synthet
dna
vaccin
encod
toxin
toxin
b
receptorbind
domain
c
difficil
induc
protect
antibodi
dna
vaccin
best
optimum
prophylaxi
extracellular
bacterium
infect
one
nontoxigen
c
difficil
strain
express
provid
mice
full
protect
infect
hypervirul
c
difficil
strain
ribotyp
promis
oral
vaccin
candid
cd
mention
paper
still
need
long
time
evalu
whether
surviv
anim
antibiot
treatment
anoth
strategi
develop
novel
chimer
toxin
vaccin
retain
major
neutral
epitop
toxin
confer
complet
protect
subunit
vaccin
becom
promis
measur
therefor
design
recombin
rbd
refer
strain
vaccin
candid
studi
immun
mice
recombin
rbd
challeng
extract
crude
toxin
hypervirul
strain
sever
variat
hypervirul
strain
rt
exist
caus
high
infect
rate
drug
resist
consequ
morbid
mortal
rate
strain
higher
strain
next
need
evalu
protect
toxin
c
difficil
atcc
strain
confer
vaccin
target
rbd
toxin
andor
toxin
b
c
difficil
refer
strain
result
confirm
rbdtcda
rbdtcdb
highli
immunogen
mice
investig
subtyp
predomin
mice
immun
vaccin
candid
igg
subtyp
assay
elisa
found
signific
increas
absorb
antigenspecif
ratio
vaccin
group
suggest
vaccin
elicit
immun
respons
princip
role
toxinneutr
circul
antibodi
immun
c
difficil
also
clearli
demonstr
anim
model
studi
identifi
character
efficaci
toxin
rbdneutral
antibodi
crude
toxin
sera
immun
mice
neutral
certain
dose
crude
toxin
vitro
neutral
assay
neutral
antibodi
titer
induc
rbdtcdab
vaccin
much
higher
induc
two
unival
vaccin
could
set
stabl
challeng
anim
model
spore
bacterium
stain
atcc
wherea
still
stuck
use
crude
toxin
strain
challeng
repeatedli
appear
chines
hospit
year
deliveri
crude
toxin
intraperiton
lethal
mice
howev
system
toxin
indic
normal
infect
scenario
entri
toxin
circul
thought
possibl
caus
therefor
challeng
immun
mice
intraperiton
toxin
repres
stringent
method
research
howev
tri
make
spore
bacterium
establish
anim
cdi
model
develop
vaccin
wide
rang
diseas
symptom
near
futur
order
evalu
protect
confer
vaccin
candid
immun
mice
challeng
natur
crude
toxin
extract
strain
atcc
among
three
vaccin
candid
rbdtcdab
vaccin
elicit
strongest
humor
immun
respons
provid
greatest
protect
toxin
c
difficil
import
reason
observ
must
rbdtcdab
vaccin
induc
product
type
higher
level
rbdspecif
antibodi
block
two
toxin
rbd
inhibit
action
toxin
moreov
toxin
use
adjuv
sever
research
model
studi
found
antitoxin
antitoxin
b
neutral
antibodi
titer
induc
rbdtcdab
vaccin
much
higher
induc
singl
one
toxin
b
potent
cytotoxin
toxic
time
high
toxin
thu
presum
rbdtcdb
function
adjuv
case
rbdtcdab
vaccin
activ
broader
spectrum
bcell
clone
unival
vaccin
caus
differ
protect
level
offer
toxin
protect
data
got
anim
experi
aid
us
develop
safe
effect
vaccin
human
be
mice
also
immun
differ
dose
evalu
relationship
immun
dose
confer
protect
result
show
statist
signific
differ
immun
effect
two
dose
mice
challeng
mld
crude
toxin
need
work
address
find
mechan
studi
prove
first
time
vaccin
base
rbd
induc
signific
humor
immun
respons
c
difficil
data
decis
demonstr
even
small
dose
bival
vaccin
candid
confer
remark
protect
toxin
c
difficil
host
indic
rbd
use
rel
efficaci
target
immun
